Octapharma AG - Company & Market Research Reports

Home /
Companies /
Octapharma AG

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

REFINE BY

KEYWORD

Hyperimmune Globulin Injection Market - Global Forecast to 2030

 Report
August 2025
197 Pages
Global

From

€3154EUR$3,545USD£2,769GBP

€3505EUR$3,939USD£3,076GBP

Blood Plasma Derivatives Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

 Report
January 2025
93 Pages
Global

From

€3500EUR$4,214USD£3,180GBP

Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Application, and End User

 Report
March 2023
209 Pages
Global

From

€3959EUR$4,450USD£3,475GBP

Blood Coagulation Factor Activators - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1068EUR$1,200USD£937GBP

€1335EUR$1,500USD£1,171GBP

Blood Plasma Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
95 Pages
Global

From

€3500EUR$4,214USD£3,180GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Intravenous Immunoglobulin Market by Application and Type: Global Opportunity Analysis and Industry Forecast, 2027

 Report
July 2023
179 Pages
Global

From

€4004EUR$4,500USD£3,514GBP

Blood Plasma Colloid Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
103 Pages
Global

From

€3500EUR$4,214USD£3,180GBP

Intravenous Immunoglobulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
June 2025
275 Pages
Global

From

€4444EUR$4,995USD£3,901GBP

Hypofibrinogenemia - Pipeline Insight, 2025

 Clinical Trials
April 2025
40 Pages
Global

From

€890EUR$1,000USD£781GBP

€1112EUR$1,250USD£976GBP

Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

 Report
August 2022
Global

From

€4004EUR$4,500USD£3,514GBP

Blood Plasma Market: Analysis By Demand, By Production Capacity, By Type, By Industry, By Application, By Region, Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2028

 Report
July 2023
147 Pages
Global

From

€2002EUR$2,250USD£1,757GBP

Antihemophilic Factor (Recombinant) Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

 Report
November 2024
88 Pages
Global

From

€3500EUR$4,214USD£3,180GBP

Human Coagulation Factor VII Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
93 Pages
Global

From

€3500EUR$4,214USD£3,180GBP

Human Coagulation Factor VIII Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
111 Pages
Global

From

€3500EUR$4,214USD£3,180GBP

Human Fibrin Sealant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
88 Pages
Global

From

€3500EUR$4,214USD£3,180GBP

Human serum albumin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
101 Pages
Global

From

€3500EUR$4,214USD£3,180GBP

Human Coagulation Factor IV Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
104 Pages
Global

From

€3500EUR$4,214USD£3,180GBP

Thrombin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
91 Pages
Global

From

€3500EUR$4,214USD£3,180GBP

Fibrinogen Deficiency Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
82 Pages
Global

From

€3500EUR$4,214USD£3,180GBP

Intravenous Immunoglobulin Market Report: Trends, Forecast and Competitive Analysis to 2031

 Report
March 2025
150 Pages
Global

From

€3425EUR$3,850USD£3,007GBP

€4315EUR$4,850USD£3,788GBP

267 Results (Page 5 of 14)
- 1
- 3
- 4
- 5
- 6
- 7

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.